MedTrace Logo

Surgical or Catheter Ablation of Lone Atrial Fibrillation (AF) Patients

NCT00703157 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-05-16

Study results available
· View outcomes & findings →

Summary

Prospective randomized interventional trial comparing the efficacy of circumferential pulmonary vein ostia ablation using surgical versus catheter techniques in the treatment of paroxysmal atrial fibrillation. Success rate determined by REVEAL-XT (AF implantable monitoring device).

Conditions

Interventions

PROCEDURE

Catheter Ablation

Patients undergoing left atrial circumferential pulmonary vein ostia ablation.

PROCEDURE

Surgical Ablation

patients undergoing left atrial circumferential pulmonary vein ostia ablation via minimal invasive surgery.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Hauw Sie, MD · Isala

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2015-08-31
Completion
2016-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00703157 on ClinicalTrials.gov